Jeffrey Poiley
Rheumatology · Orlando, FLNPI 1487713483
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,903 and has fallen 87.2% since, to $243 in 2025. That places this record below the midpoint for rheumatology clinicians in FL, where the typical reported total is $6,335.
Across 86 payments — averaging $25.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$365
- Pfizer$330
- Amgen$320
- E.r. Squibb & Sons, L.L.C.$211
- Sanofi$204
- Genentech USA, Inc.$137
- plus $599 from 8 others
Across 38 payments — averaging $2724.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$68K
- Amgen$8K
- AbbVie$7K
- Eli Lilly$6K
- Sanofi US Services Inc.$5K
- GSK$3K
- plus $6K from 5 others
What the payments were for
- Food & beverage$2,166100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 11 | $365 |
| Pfizer | 8 | $330 |
| Amgen | 16 | $320 |
| E.r. Squibb & Sons, L.L.C. | 14 | $211 |
| Sanofi | 2 | $204 |
| Genentech USA, Inc. | 2 | $137 |
| GSK | 6 | $133 |
| UCB, Inc. | 7 | $117 |
| Johnson & Johnson(2 entities) | 6 | $103 |
| Lilly USA, LLC | 5 | $99 |
| AbbVie | 5 | $89 |
| Mallinckrodt Enterprises LLC | 2 | $29 |
| Bristol Myers Squibb | 1 | $15 |
| Sobi, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,166 in reported general payments places this provider in the 30th percentile of 453 rheumatology providers in Florida.
Other rheumatology in Orlando
- Waleed BoladOrlando$115K
- Anika AlarakhiaOrlando$63K
- Alvin WellsDestin$2.4M
- Guillermo ValenzuelaPlantation$1.5M
- Julio Gonzalez-PaoliTampa$1.4M
- Ernesto RodriguezZephyrhills$958K
- Vinicius Costa Diniz DominguesDaytona Beach$921K
- Jonathan GreerBoynton Beach$757K
- Jigar ShahMargate$750K
- Rachel TateHollywood$729K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.